Best practice recommendations for the management of anxiety during the pegvaliase journey-Reference-Cited by-同舟云学术

Best practice recommendations for the management of anxiety during the pegvaliase journey

Published:2024-01 Issue:1 Volume:141 Page:107737
ISSN:1096-7192
Container-title:Molecular Genetics and Metabolism
language:en
Short-container-title:Molecular Genetics and Metabolism

Author:

Bjoraker Kendra J.,Eggerding Caroline,Ellenberg Elisheva,Hollander Suzanne,Holmes Brittany M.,Lindstrom Kristin,McNutt Markey,Miller Suzanne,Northrup Hope,Rogers Meaghan,Rose Sarah,Scott Mia,Shim Soo,Wardley Bridget,Wessenberg Leah,Bilder Deborah A.

Funder

BioMarin Pharmaceutical Inc

Publisher

Elsevier BV

Subject

Endocrinology,Genetics,Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference66 articles.

1. Psychiatric and cognitive aspects of phenylketonuria: the limitations of diet and promise of new treatments;Ashe;Front. Psychol.,2019

2. Systematic review and meta-analysis of neuropsychiatric symptoms and executive functioning in adults with phenylketonuria;Bilder;Dev. Neuropsychol.,2016

3. Psychiatric disorders in adolescent and young adult patients with phenylketonuria;Manti;Mol. Genet. Metab.,2016

4. Phenylalanine hydroxylase deficiency: diagnosis and management guideline;Vockley;Genet. Med.,2014

5. The complete European guidelines on phenylketonuria: diagnosis and treatment;van Wegberg;Orphanet J. Rare Dis.,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre-analytic decrease of phenylalanine in plasma of patients with phenylketonuria treated with pegvaliase;Molecular Genetics and Metabolism Reports;2024-09

2. Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018: Is It a Changing Landscape?;Nutrients;2024-06-28